Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.
Derya TilkiMing-Hui ChenJing WuHartwig HulandMarkus GraefenOsama MohamadJanet E CowanPeter R CarrollAnthony V D'AmicoPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Among patients with at most one high-risk factor, initiating sRT above a PSA level of 0.25 ng/mL was associated with increased ACM-risk.